Literature DB >> 12163368

A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.

Christian R Engwerda1, Manabu Ato, Sara E J Cotterell, Tracey L Mynott, Asiya Tschannerl, Patricia M A Gorak-Stolinska, Paul M Kaye.   

Abstract

The development of secondary lymphoid organs is a highly regulated process, mediated by tumor necrosis factor (TNF) family cytokines. In contrast, the mechanisms controlling changes in lymphoid architecture that occur during infectious disease are poorly understood. Here we demonstrate that during infection with Leishmania donovani, the marginal zone of mice undergoes extensive remodeling, similar in extent to developmental abnormalities in mice lacking some TNF family cytokines. This process is selective, comprising a dramatic and rapid loss of marginal zone macrophages (MZMs). As a functional consequence, lymphocyte traffic into the white pulp is impaired during chronic leishmaniasis. Significantly, MZMs were preserved in L. donovani-infected B6.TNF-alpha(-/-) mice or mice that received anti-TNF-alpha antibodies, whereas studies in CD8(+) T-cell-deficient mice and in mice lacking functional CD95L, excluded a direct role for either cytotoxic T lymphocyte activity or CD95-mediated apoptosis in this process. Loss of MZMs was independent of parasite burden, yet could be partially prevented by chemotherapy, which in turn reduced endogenous TNF-alpha levels. This is the first report of an infectious agent causing selective and long-lasting changes to the marginal zone via TNF-alpha-mediated mechanisms, and illustrates that those cytokines involved in establishing lymphoid architecture during development, may also play a role in infection-induced lymphoid tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163368      PMCID: PMC1850733          DOI: 10.1016/s0002-9440(10)64199-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

1.  Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice.

Authors:  P A Koni; R Sacca; P Lawton; J L Browning; N H Ruddle; R A Flavell
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

2.  Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions.

Authors:  G Franzoso; L Carlson; T Scharton-Kersten; E W Shores; S Epstein; A Grinberg; T Tran; E Shacter; A Leonardi; M Anver; P Love; A Sher; U Siebenlist
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

3.  Destruction of follicular dendritic cells during chronic visceral leishmaniasis.

Authors:  S C Smelt; C R Engwerda; M McCrossen; P M Kaye
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

Review 4.  Role of Lsh in regulating macrophage priming/activation.

Authors:  J M Blackwell; T I Roach; A Kiderlen; P M Kaye
Journal:  Res Immunol       Date:  1989-10

5.  Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.

Authors:  F Mackay; G R Majeau; P Lawton; P S Hochman; J L Browning
Journal:  Eur J Immunol       Date:  1997-08       Impact factor: 5.532

6.  Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy.

Authors:  L Weiss
Journal:  Am J Trop Med Hyg       Date:  1989-08       Impact factor: 2.345

7.  Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.

Authors:  H W Murray; M J Oca; A M Granger; R D Schreiber
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

8.  An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.

Authors:  C R Engwerda; S C Smelt; P M Kaye
Journal:  Exp Parasitol       Date:  1996-11       Impact factor: 2.011

9.  Tumor necrosis factor (cachectin) in human visceral leishmaniasis.

Authors:  M Barral-Netto; R Badaró; A Barral; R P Almeida; S B Santos; F Badaró; D Pedral-Sampaio; E M Carvalho; E Falcoff; R Falcoff
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

10.  A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling.

Authors:  L Alexopoulou; M Pasparakis; G Kollias
Journal:  Eur J Immunol       Date:  1997-10       Impact factor: 5.532

View more
  65 in total

1.  Leishmania donovani Lipophosphoglycan Increases Macrophage-Dependent Chemotaxis of CXCR6-Expressing Cells via CXCL16 Induction.

Authors:  Visnu Chaparro; Louis-Philippe Leroux; Aude Zimmermann; Armando Jardim; Brent Johnston; Albert Descoteaux; Maritza Jaramillo
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

2.  Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.

Authors:  Arnaud Machelart; Abir Khadrawi; Aurore Demars; Kevin Willemart; Carl De Trez; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 3.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

4.  Massive destruction of malaria-parasitized red blood cells despite spleen closure.

Authors:  Jürgen Krücken; Liv I Mehnert; Mohamed A Dkhil; Manal El-Khadragy; W Peter M Benten; Horst Mossmann; Frank Wunderlich
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 5.  Role of chemokines in regulation of immunity against leishmaniasis.

Authors:  Steve Oghumu; Claudio M Lezama-Dávila; Angelica P Isaac-Márquez; Abhay R Satoskar
Journal:  Exp Parasitol       Date:  2010-03-03       Impact factor: 2.011

6.  Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Simona Stäger; Clare E Alexander; Amanda C Stanley; Paul M Kaye
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

8.  Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.

Authors:  Stanislaw Gorski; Simon M Collin; Koert Ritmeijer; Kees Keus; Francis Gatluak; Marius Mueller; Robert N Davidson
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

9.  Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.

Authors:  J Brian de Souza; Uduak Okomo; Neal D Alexander; Naveed Aziz; Benjamin M J Owens; Harparkash Kaur; Momodou Jasseh; Sant Muangnoicharoen; Percy F Sumariwalla; David C Warhurst; Stephen A Ward; David J Conway; Luis Ulloa; Kevin J Tracey; Brian M J Foxwell; Paul M Kaye; Michael Walther
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

Review 10.  Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease.

Authors:  S-K Friedrich; P A Lang; J Friebus-Kardash; V Duhan; J Bezgovsek; K S Lang
Journal:  Clin Exp Immunol       Date:  2019-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.